Nona Biosciences, a global pioneer of technology innovation and antibody discovery and development solutions, and INGENIA Therapeutics, a preclinical-stage biotech company

Mundipharma and Cidara Therapeutics (Nasdaq: CDTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has

AGC Biologics , a leading global biopharmaceutical contract developer and manufacturer (CDMO), today announced the completion of facility expansion for its new plasmid DNA (pDNA)

Cyrano Therapeutics, Inc., a regenerative medicine company pioneering the development of treatments for smell loss, announced today that it has commenced enrollment in the Phase 2

Lucy Therapeutics (LucyTx) has obtained additional funding from the International Rett Syndrome Foundation (IRSF) to support innovative treatments for individuals, both children and adults, grappling with Rett syndrome. This funding will also contribute to the expansion of LucyTx's pioneering treatment platform.

Eurofins CDMO Alphora Inc. announces that it has received its Health Canada Cannabis Drug License issued within the Cannabis Act and Cannabis Regulations for its Oakville, Ontario operations in September 2023. This compliments the Institutional Research License obtained through Health Canada in June 2021 for its Mississauga development site and a Standard Processing License obtained for the Oakville, Ontario manufacturing operation in May 2022.

Gritgen Therapeutics Co., Ltd., a biotechnology company specializing in the discovery and development of cutting-edge gene therapy products, is pleased to announce the successful validation and official commencement of operations at its commercial Good Manufacturing Practices (GMP) facility located in Suzhou Industrial Park.

Fujirebio Holdings, Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Goki Ishikawa) and Sysmex Corporation (Headquarters: Kobe, Japan; President: Kaoru Asano) jointly announce a Basic Agreement on Business Collaboration to foster a multifaceted partnership encompassing research and development, production, clinical development, and sales-marketing in the field of immunoassay.

A major advancement in pharmaceutical cleanroom technology has been achieved with the launch of new automated systems.

The latest regulatory compliance guidelines impact clinical trials across Asia.